Lipertance (Amlodipine Besilate, Perindopril Arginine, Atorvastatin Calcium Trihydrate)

Lipertance combines agents that act on blood pressure regulation and lipid metabolism, and is used for the following clinical indications:

• Hypertension: lowers systolic and diastolic blood pressure, helping achieve target levels.
• Hyperlipidaemia: reduces LDL‑cholesterol and total cholesterol, supporting lipid control.
• Cardiovascular risk reduction: decreases the likelihood of major adverse cardiovascular events in patients with multiple risk factors.

• Amlodipine besilate blocks L‑type calcium channels in vascular smooth muscle, causing vasodilation; Perindopril arginine inhibits angiotensin‑converting enzyme, reducing angiotensin II‑mediated vasoconstriction and aldosterone release; Atorvastatin calcium trihydrate inhibits HMG‑CoA reductase, the rate‑limiting enzyme in cholesterol biosynthesis, thereby lowering circulating LDL and total cholesterol.

Lipertance may cause a range of adverse reactions. The most frequently reported events are generally mild and reversible.

Common Side Effects

• Headache: mild to moderate intensity.
• Peripheral edema: swelling of ankles or lower legs.
• Cough: dry, persistent throat irritation.
• Dizziness or light‑headedness.
• Muscle pain or weakness.
• Gastrointestinal upset: nausea, abdominal discomfort.

Serious or Rare Side Effects

• Angioedema: swelling of face, lips, tongue, or airway.
• Severe liver injury: jaundice, elevated transaminases.
• Rhabdomyolysis: muscle breakdown with dark urine.
• Significant hypotension: marked drop in blood pressure.
• Pancreatitis: abdominal pain with elevated enzymes.
• Anaphylactic reaction: severe allergic response requiring emergency care.

Before initiating Lipertance, clinicians should consider several safety aspects.

• Blood pressure monitoring: obtain baseline readings and reassess after dose changes.
• Renal function: evaluate creatinine and eGFR, especially in patients with chronic kidney disease.
• Hepatic enzymes: monitor liver function tests due to the statin component.
• Electrolyte balance: watch potassium and sodium levels when combined with diuretics.
• Pregnancy and lactation: prescribe only if potential benefits outweigh risks.
• Store at ambient temperature: keep below 25 °C, retain in original packaging, protect from moisture.

Lipertance interacts with several drug classes; awareness of major and moderate interactions helps avoid adverse outcomes.

Major Interactions (Avoid)

• Strong CYP3A4 inhibitors (e.g., itraconazole): increase atorvastatin exposure.
• Concomitant ACE inhibitors or ARBs: risk excessive hypotension and renal impairment.
• Fibrates such as gemfibrozil: heightened risk of myopathy.
• Aliskiren in diabetic patients: contraindicated due to renal risk.
• Lithium: may raise lithium serum concentrations.

Moderate Interactions (Monitor Closely)

• NSAIDs: may blunt antihypertensive effect.
• Diuretics: can potentiate hypotension and electrolyte shifts.
• Antacids containing aluminum/magnesium: may affect amlodipine absorption.
• Beta‑blockers: additive blood pressure lowering.
• Grapefruit juice: may increase amlodipine plasma levels.